Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers
<p>Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers</p>
<p>Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers</p>
Share This Story